REGENTS OF THE UNIVERSITY OF MINNESOTA V. GILEAD SCIENCES, INC.
Before Lourie, Dyk, and Stoll. Appeal from the Patent Trial and Appeal Board.
Summary: For drug patents, adequate written description of a broad genus...more
3/7/2023
/ Food and Drug Administration (FDA) ,
Gilead Sciences ,
Inter Partes Review (IPR) Proceeding ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Prescription Drugs